Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share News

Burberry, recently debuted Metlen Energy & Metals to join FTSE 100

3rd Sep 2025 19:40

(Alliance News) - Burberry Group PLC and Metlen Energy & Metals PLC have been promoted to the FTSE 100 in its latest quarterly shuffle, with Taylor Wimpey PLC and Unite Group PLC relegated from the benchmark index. Read More

LONDON BROKER RATINGS: Morgan Stanley lifts BP; Investec cuts Domino's

3rd Sep 2025 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

Metlen Energy set for FTSE 100, replacing Taylor Wimpey - FTSE Russell

26th Aug 2025 17:29

(Alliance News) - Metlen Energy & Metals PLC is set to join the FTSE 100 at the first time of asking, at the expense of housebuilder Taylor Wimpey PLC, data from FTSE Russell suggested on Tuesday. Read More

LONDON BROKER RATINGS: Deutsche Bank cuts Kingfisher and AB Foods

26th Aug 2025 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Friday: Read More

LONDON BRIEFING: Stocks down, Pri0r1ty approved for US listing

26th Aug 2025 07:47

(Alliance News) - Stocks were called to open lower on Tuesday, while in corporate news British American Tobacco's chief financial officer is stepping down. Read More

Oxford BioMedica raises GBP60 million to fund US expansion

15th Aug 2025 15:59

(Alliance News) - Oxford BioMedica PLC on Friday said it has raised GBP60 million through a share placing and subscription to support expansion in the US and boost process productivity. Read More

SMALL-CAP WINNERS: Oxford BioMedica fundraise nets about GBP60 million

15th Aug 2025 10:41

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

IN BRIEF: Oxford Biomedica to refinance debt with USD125 million loan

1st Aug 2025 12:52

Oxford Biomedica PLC - Oxford, England-based gene and cell therapy developer - Says it has a new loan facility with Oaktree Capital Management LP worth up to USD125 million over four years. Expects USD60 million upfront funding to be available when the deal closes. Plans to use this to repay an existing USD50 million loan from Oaktree. Notes that the loan includes option to draw down further USD25 million and additional USD40 million, subject to revenue targets. Says this increases flexibility to grow global contract development and manufacturing operations. Notes also that the loan will not amortise, with the full aggregate principal and outstanding amount due in 2029. Read More

SMALL-CAP WINNERS & LOSERS: Ceres gets Korea boost; STV takes ad hit

28th Jul 2025 10:40

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

Oxford BioMedica holds outlook as revenue jumps and order book boosted

28th Jul 2025 09:33

(Alliance News) - Oxford BioMedica PLC on Monday said it expects to report a jump in revenue in the first half of the year as its order book more than doubled. Read More

LONDON BROKER RATINGS: Citi resumes at Aviva at 'neutral'

15th Jul 2025 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

SMALL-CAP WINNERS & LOSERS: LMS Capital rises on capital return plan

8th Jul 2025 10:31

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

LONDON BROKER RATINGS: BofA raises Persimmon; Citi cuts Man Group

8th Jul 2025 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

Oxford BioMedica completes purchase of last 10% stake in US subsidiary

23rd Jun 2025 11:56

(Alliance News) - Oxford BioMedica PLC on Monday said it has completed the acquisition of the remaining 10% stake in its US subsidiary from Massachusetts, US-based biotechnology firm Q32 Bio Inc. Read More

Oxford BioMedica touts strong first-half momentum ahead of meeting

11th Jun 2025 10:55

(Alliance News) - Oxford BioMedica PLC reported "strong commercial momentum" during the first half of the year, in a statement ahead of its annual general meeting on Wednesday. Read More

SMALL-CAP WINNERS & LOSERS: Castings warns on continued lower demand

11th Jun 2025 10:03

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday. Read More

UK shareholder meetings calendar - next 7 days

4th Jun 2025 13:05

Read More

SMALL-CAP WINNERS & LOSERS: Petra Diamonds postpones Cullinan sales

9th Apr 2025 10:59

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday. Read More

Oxford Biomedica annual loss narrows; hails "commercial momentum"

9th Apr 2025 09:30

(Alliance News) - Oxford BioMedica PLC on Wednesday said its client portfolio continued to expand and diversify, noting it was on track to achieve "significant" revenue growth consistent with medium-term guidance. Read More

LONDON BRIEFING: Assura rejects PHP bid; Oxford BioMedica narrows loss

9th Apr 2025 07:53

(Alliance News) - London's FTSE 100 is called to open lower on Wednesday following the announcement of new further US tariffs on China, and global markets brace themselves for further turmoil. Read More

FTSE 100 Latest
Value9,242.53
Change0.00